About
Ms. Christiana Stamoulis was appointed as Chief Financial Officer, Executive Vice President of the company effective February 11, 2019. She as served as President since February 2018 and Chief Financial Officer since January 2015 of Unum Therapeutics Inc., a biopharmaceutical company, and has resigned from those roles effective January 31, 2019. From January 2014 until she joined Unum, Ms. Stamoulis was an independent advisor to biopharmaceutical companies. From 2009 until December 2013, Ms. Stamoulis was a Senior Vice President of Corporationrationrate Strategy and Business Development at Vertex Pharmaceuticals, Inc., a biopharmaceutical company. Prior to joining Vertex, Ms. Stamoulis spent nearly 15 years in the investment banking and management consulting industries. She was a Managing Director in the Investment Banking division of Citigroup and, prior to that, she was a senior investment banker in the Healthcare Investment Banking Group of Goldman, Sachs Co., where she spent the majority of her investment banking career. Ms. Stamoulis started her career as a strategy consultant at The Boston Consulting Group. Ms. Stamoulis has served as a member of the board of directors of Hologic Inc., a medical technology company, since November 2011 since 2019.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Chief Financial Officer
Unum GroupAppointed Date: 01/01/2015
Date Resigned: 31/01/2019
Industry: Insurance
View Company
President
Vertex Pharmaceuticals IncorporatedAppointed Date:
Date Resigned:
Industry: Pharmaceutical
View Company
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Hologic, Inc. | Audit | Member | 01/02/2019 | |
| Hologic, Inc. | Board | Member | 01/02/2019 |